Navigation Links


visible at Biology News

Medical molecules designed to respond to visible light that can penetrate tissue

If you have ever covered a flashlight with your hand and seen the red light that still comes through, then you have seen light in the therapeutic window ?that magic wavelength that is not absorbed or reflected away by tissue. Scientists believe that they can use light at that wavelength to signal manmade molecules to release drugs at disease sites in the body. Such possibilities will be d...
visible at Biology Products
visible at Biology Technology

A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20)

β -lactamases are either plasmid or chromosomally encoded bacterial enzymes which hydrolyze β -lactam antibiotics. The majority of β -lactamases produced by clinical isolates are serine active site enzymes. One successful approach to combating the serine active site β -lactamases is the use of β -lactamase inhibit...

ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION

Amino Acids, RP-HPLC, Precolumn derivatisation, o-Phthalaldehyde (OPA), 2-Mercaptopropionic acid, Ultraviolet detection. Introduction: Underivatised amino acids do not significantly absorb light in the UV/visible spectrum. In order to increase sensitivity, their analysis normally includes a derivatisation step in whic...
visible at Medicine News

Invisible Gases Form Most Organic Haze in Urban, Rural Areas: Study

A University of Colorado at Boulder study has claimed that invisible and reactive gases hovering over the Earth's surface , form the bulk of organic haze in both urban and rural areas. Till now, the scientists and health professionals had believed that sources that spew soot and other tiny particles directly into the air were the primary culprit in the formation of organic haze. <b...
visible at Medicine Products

DU 500 UV/Visible Spectrophotometers

Description:DU 520 General Purpose UV/Vis Spectrophotometer. Beckman coulter UV/visible spectrophotometers provide ease-of-use and proven technology for a wide range of applications. The affordable DU Series 500 Scanning Spectrophotometers, with easily interchangeable sampling modules, are ideal for routine use. A totally affordable, completely modular UV/V is Spectrophotometer which provides easy sample han...
Company:Beckman Coulter, Inc.

Model 420 UV Visible Spectrophotometer

Description:400 Series Spectrophotometer is truly a revolutionary approach to UV-VIS instrumentation. The latest electro-optical technologies are incorporated into a radically new design, resulting in features and performance unprecedented in a laboratory grade UV Visible spectrophotometer....
Company:S.I. Photonics, Inc.

Model 410 Visible Spectrophotometer

Description:400 Series Spectrophotometer is truly a revolutionary approach to UV-VIS instrumentation. The latest electro-optical technologies are incorporated into a radically new design, resulting in features and performance unprecedented in a laboratory grade UV Visible spectrophotometer....
Company:S.I. Photonics, Inc.

Model 430 Visible Spectrophotometer High Resolution

Description:400 Series Spectrophotometer is truly a revolutionary approach to UV-VIS instrumentation. The latest electro-optical technologies are incorporated into a radically new design, resulting in features and performance unprecedented in a laboratory grade UV Visible spectrophotometer....
Company:S.I. Photonics, Inc.

Model 440 UV Visible Spectrophotometer

Description:400 Series Spectrophotometer is truly a revolutionary approach to UV-VIS instrumentation. The latest electro-optical technologies are incorporated into a radically new design, resulting in features and performance unprecedented in a laboratory grade UV Visible spectrophotometer....
Company:S.I. Photonics, Inc.
visible at Medicine Technology
Other TagsWesternWesternWesternWesternWestern
(Date:10/11/2008)... Barnett International, a... has announced the release of The Form FDA 1572: A...s, and Monitors. Designed for clinical investigato...y affairs professionals, and others involved in th... reference guide to address the Form FDA 1572-Stat...
(Date:10/10/2008)... PACO Communications Named Agency ...gian American Hospital has just,announced the laun...signed,to build awareness of its long-standing com... and care through its Labor and Delivery, Special ... rolled out in Chicago with a focus on public rela...
(Date:10/10/2008)...1 in 6 likely to develop some form of disease by 2...FRIDAY, Oct. 10 (HealthDay News) -- Liver transpla... the general population, say researchers in Finlan...ssue of Liver Transplantation , researchers inves...er transplant recipients from Helsinki University ...
(Date:10/10/2008)... MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/...unces that it has appointed William,(Bill) Federic...ard to five,members., Mr. Federici joined West Ph...Financial Officer in August of 2003. Under his fin...have grown to more than $1.0 billion from,$300 mil...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 2Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3
(Date:10/10/2008)...Haven, Conn. Yale scientists have created nanowir...ronics that are both sensitive and specific enough...ion, according to a report in Nano Letters . , ...ly specific antigens signatures of bacteria, viru... are activated, they produce acid, and generate a ...
(Date:10/9/2008)...NTA CLARA, Calif., Oct. 9 /PRNewswire-FirstCall/ -...ading developer of human interface,solutions for m... devices,announced today that it will report fina... on Thursday, October 23, 2008 after the close of ...erence call for analysts and,investors at 2:00 p.m...
(Date:10/9/2008)...It,s hard being a mussel: you have to worry about ...ention an environment that can change your body te...s. , "It,s one of the most variable habitats on ... can spend part of the day bathed in cool Pacific ...rnia sun." , Gracey led the first real-time mole...
(Date:10/9/2008)...National Institute of Allergy and Infectious Disea...alth (NIH), will award five-year contracts estimat... in Systems Biology for Infectious Disease Researc...h facility will apply novel techniques to study di...ome (SARS), tuberculosis and influenza. , System...
Breaking Biology News(10 mins):Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3New Systems Biology Awards enable detailed study of microbes 2Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 1Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 2Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 1Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 2Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 1Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 1Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 7
Other Contentsabortionabortionabortionabortioninevitableinevitableinevitableinevitablereflexesreflexesreflexesdistressdistressdistressbotulismbotulismbotulisminfarctinfarctinfarctinfantsinfantsinfantsinfantsinfantsinfantsinfantileinfantile